Evidence for incomplete replication of a penguin poxvirus in cells of mammalian origin.
暂无分享,去创建一个
L. Stannard | D. Marais | K. Dumbell | D. Kow
[1] M. Skinner,et al. Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells. , 1993, Virology.
[2] E. Paoletti,et al. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. , 1993, Virology.
[3] R. Doms,et al. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks , 1993, The Journal of cell biology.
[4] E. Paoletti,et al. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL , 1993, Journal of virology.
[5] B. Moss,et al. Nonreplicating vaccinia vector efficiently expresses recombinant genes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] E. Paoletti,et al. Immunisation with canarypox virus expressing rabies glycoprotein , 1992, The Lancet.
[7] E. Paoletti,et al. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. , 1992, Virology.
[8] D. Kow. Characterization of avipoxviruses for use in recombinant vaccines , 1992 .
[9] E. Paoletti,et al. Potential use of non-replicating vectors as recombinant vaccines. , 1992, Vaccine.
[10] J. Roujeau,et al. Vaccinia from recombinant virus expressing HIV genes , 1991, The Lancet.
[11] E. Paoletti,et al. Efficacy studies on a canarypox-rabies recombinant virus. , 1991, Vaccine.
[12] G. Nolan,et al. Use of Escherichiu coli (E. coli) lacZ (β-Galactosidase) as a Reporter Gene. , 1991, Methods in molecular biology.
[13] S. Goebel,et al. Vaccinia virus host range genes. , 1990, Virology.
[14] M. Binns,et al. Analysis of the fowlpoxvirus gene encoding the 4b core polypeptide and demonstration that it possesses efficient promoter sequences. , 1989, Virology.
[15] C. Caskey,et al. Construction of plasmids that express Escherichia coli β-galactosidase in mammalian cells , 1989 .
[16] E. Paoletti,et al. Recombinant fowlpox virus inducing protective immunity in non-avian species. , 1988, Vaccine.
[17] D. Spehner,et al. A cowpox virus gene required for multiplication in Chinese hamster ovary cells , 1988, Journal of virology.
[18] T. S. Jones,et al. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. , 1987, The New England journal of medicine.
[19] S. Dales,et al. Biogenesis of vaccinia: relationship of the envelope to virus assembly. , 1976, Virology.
[20] W. Russell,et al. A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses , 1975, Nature.
[21] D. Hughes,et al. The morphogenesis of pigeonpox virus. , 1972, The Journal of general virology.
[22] N. Cheville. Cytopathologic changes in fowlpox (turkey origin) inclusion body formation. , 1966, The American journal of pathology.
[23] C. Randall,et al. Electron microscopic observations on the development of fowlpox virus in chorioallantoic membrane , 1964 .
[24] W. Joklik. The purification fo four strains of poxvirus. , 1962, Virology.
[25] F. Fenner,et al. A short description of the poxvirus group (vaccinia and related viruses). , 1957, Virology.